Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.

Rikke H Dahlrot, Jørn Herrstedt, Bjarne W Kristensen, Jacob Hjelmborg, Steinbjørn Hansen, A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1 International Journal of Clinical and Experimental Pathology. ,vol. 6, pp. 31- 40 ,(2013)

Hiroko Ohgaki, Paul Kleihues, Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of Neuropathology and Experimental Neurology. ,vol. 64, pp. 479- 489 ,(2005) , 10.1093/JNEN/64.6.479

I-Wen Pan, Sherise D. Ferguson, Sandi Lam, Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000–2010 Journal of Clinical Neuroscience. ,vol. 22, pp. 1575- 1581 ,(2015) , 10.1016/J.JOCN.2015.03.032

Daisuke Kita, Ilja F. Ciernik, Salvatore Vaccarella, Silvia Franceschi, Paul Kleihues, Urs M. Lütolf, Hiroko Ohgaki, Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology. ,vol. 33, pp. 17- 22 ,(2009) , 10.1159/000210017

Matthew Koshy, John L. Villano, Therese A. Dolecek, Andrew Howard, Usama Mahmood, Steven J. Chmura, Ralph R. Weichselbaum, Bridget J. McCarthy, Improved survival time trends for glioblastoma using the SEER 17 population-based registries Journal of Neuro-oncology. ,vol. 107, pp. 207- 212 ,(2012) , 10.1007/S11060-011-0738-7

Christian Hartmann, Bettina Hentschel, Wolfgang Wick, David Capper, Jörg Felsberg, Matthias Simon, Manfred Westphal, Gabriele Schackert, Richard Meyermann, Torsten Pietsch, Guido Reifenberger, Michael Weller, Markus Loeffler, Andreas von Deimling, Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: Implications for classification of gliomas Acta Neuropathologica. ,vol. 120, pp. 707- 718 ,(2010) , 10.1007/S00401-010-0781-Z

Derek R. Johnson, Brian Patrick O’Neill, Glioblastoma survival in the United States before and during the temozolomide era. Journal of Neuro-oncology. ,vol. 107, pp. 359- 364 ,(2012) , 10.1007/S11060-011-0749-4

Michael Weller, Roger Stupp, Guido Reifenberger, Alba A. Brandes, Martin J. van den Bent, Wolfgang Wick, Monika E. Hegi, MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nature Reviews Neurology. ,vol. 6, pp. 39- 51 ,(2010) , 10.1038/NRNEUROL.2009.197

Izabela Zawlik, Salvatore Vaccarella, Daisuke Kita, Michel Mittelbronn, Silvia Franceschi, Hiroko Ohgaki, Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study. Neuroepidemiology. ,vol. 32, pp. 21- 29 ,(2009) , 10.1159/000170088

D. W. Parsons, S. Jones, X. Zhang, J. C.-H. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, I-M. Siu, G. L. Gallia, A. Olivi, R. McLendon, B. A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. A. Busam, H. Tekleab, L. A. Diaz, J. Hartigan, D. R. Smith, R. L. Strausberg, S. K. N. Marie, S. M. O. Shinjo, H. Yan, G. J. Riggins, D. D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu, K. W. Kinzler, An Integrated Genomic Analysis of Human Glioblastoma Multiforme Science. ,vol. 321, pp. 1807- 1812 ,(2008) , 10.1126/SCIENCE.1164382